About Standard
News
Products info
Research Development & Innovation
For Investors
Corporate Governance
Board of DiretorsShare Holder Meeting
Share Holder MeetingDividends
Dividends
About Standard
News
Products info
Research Development & Innovation
For Investors
Standard is a leader in Taiwan generic pharmaceutical market in terms of prescriptions filled, sales volume and value.
Standard is also an emerging leader in Asia Pacific markets and is seeking to rapidly broaden its product portfolio through in-licensing.
The following International markets are of interest to Standard:
Taiwan |
Cambodia |
Singapore |
Mainland China |
Indonesia |
Thailand |
Japan |
Malaysia |
Vietnam |
Korea |
Philippines |
Early to market opportunities: Standard has substantial experience in identifying, developing, and registering in early to market opportunities.
(1) first-to-file
(2) non-infringing API and/or formulations
Dosage Forms Standard does not manufacture
Inhalation | Dry Powder Inhalers Metered Dose Inhalers |
Injectable | Depots Hormones Liposomal Pre-filled Syringes |
Orals | Hormones Buccal/transmucosals |
Sales and marketing to government and private market segments
Negotiation with pricing and reimbursement authorities, contracts, bids, tenders
Conduct of bioequivalence studies (if repeat studies against local reference product is required)
Registration and maintenance of Marketing Authorizations
Pharmacovigilance
Supply chain logistics – importation, warehousing and distribution
Packaging – we can take product in either bulk or finished packaged form
Release testing (if required)